Nawaloka Hospitals Plc
CCSELK:NHL.N00009.50
LKR
-0.40
(-4.04%)
ISIN
LK0342N00002
Return %
Stock
S&P 500
1Y
-5.00
14.39
3Y
137.50
81.42
5Y
5.56
68.62
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Hewa Komanage Jayantha Dharmadasa
- Full Time Employees
- 2,005
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Colombo Sri Lanka
- IPO Date
- Aug 8, 2004
- Website
- nawaloka.com
- Similar Companies
- Business
- Nawaloka Hospitals PLC is a Sri Lanka-based private healthcare provider engaged in delivering comprehensive multi-specialty tertiary medical care, clinical diagnostics, and outpatient health services. Founded in 1985 and headquartered in Colombo, Sri Lanka, the company operates an integrated healthcare network comprising tertiary hospitals, specialized clinical units, Medicare hubs, and diagnostic laboratories. Nawaloka Hospitals PLC provides an extensive portfolio of medical solutions and healthcare services, which include: 24-hour emergency and trauma care supported by rapid-response ambulance services and Emergency Treatment Units (ETUs); critical care infrastructure comprising adult Intensive Care Units (ICUs), Coronary Care Units (CCUs), and Neonatal Intensive Care Units (NICUs); complex surgical specialties spanning cardiothoracic surgery, neurosurgery, orthopedics, urology, and minimally invasive laparoscopic procedures; advanced diagnostic imaging services featuring AI-assisted magnetic resonance imaging (MRI), computed tomography (CT), digital radiography, 4D ultrasound, echocardiography, bone mineral densitometry (DEXA), and FibroScan technology; comprehensive pathology and clinical laboratory testing services; specialized outpatient clinics covering oncology, diabetes and endocrinology, nephrology and hemodialysis, fertility and reproductive medicine, ophthalmology and LASIK surgery, gastroenterology, and physical rehabilitation; retail and hospital-based pharmacy networks; structured executive wellness and preventive health screening packages; and digital healthcare solutions via the NawalokaCare mobile application and online doctor channeling platform. The company serves domestic and international patients through its flagship multi-specialty hospital complex in Colombo, its regional general hospital in Negombo, and decentralized medical centres across Sri Lanka, operating via subsidiaries and joint ventures including Nawaloka Medicare (Pvt) Ltd, New Nawaloka Medical Centre (Pvt) Ltd, and Nawaloka Metropolis Laboratories (Pvt) Ltd. In recent developments, Nawaloka Hospitals PLC completed a major financial restructuring, successfully concluding strategic debt settlement agreements with financial institutions to strengthen balance sheet liquidity and achieve a net profitability turnaround. Operationally, the company expanded its surgical infrastructure by increasing its operating theatre complex from 12 to 16 state-of-the-art surgical suites, introduced South Asia's first AI-powered Radiology Centre, launched AI-driven clinical interaction platforms including the NASHA digital assistant, and expanded its global medical tourism footprint through its dedicated International Patient Care Centre (IPCC) and ELITE Medical Centre.